🔥 Hot off the press
Prof John Stone shares results from Phase 3 of REPLENISH, out only a few days ago, in which secukinumab met all primary endpoints in treatment of PMR.
https://t.co/RlcQWybKrR
#ACR25 @RheumNow https://t.co/ucNt2HxJpW
Links:
REPLENISH - Secukinumab Works in Polymyalgia Rheumatica | RheumNow
https://rheumnow.com/news/replenish-secukinumab-works-polymyalgia-rheumatica
25-10-2025
